Aya Shiba-Ishii Selected Research

Aya Shiba-Ishii Research Topics

Disease

11	Neoplasms (Cancer) 09/2022 - 08/2013
10	Adenocarcinoma of Lung 12/2021 - 03/2017
4	Adenocarcinoma 05/2024 - 03/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2018
2	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 04/2011
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 12/2021
1	Carcinogenesis 08/2019
1	Adenomyosis 03/2014
1	Rhabdoid Tumor (Rhabdoid Tumors) 08/2013
1	Lymphatic Metastasis 11/2011
1	Neoplasm Metastasis (Metastasis) 04/2011
1	Clear Cell Adenocarcinoma 04/2011
1	Spontaneous Abortion (Miscarriage) 04/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2022 - 04/2011
4	Biomarkers (Surrogate Marker)IBA 02/2019 - 03/2014
3	RNA (Ribonucleic Acid)IBA 12/2021 - 03/2014
2	AntigensIBA 12/2021 - 11/2018
2	CarcinogensIBA 08/2019 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 02/2019 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 03/2017
2	Ubiquitin-Specific ProteasesIBA 10/2018 - 06/2017
2	Formaldehyde (Formol)FDA Link 08/2018 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 06/2017 - 08/2013
1	Colloids (Colloid)IBA 05/2024
1	Type 4 Fibroblast Growth Factor ReceptorIBA 09/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	lorlatinibIBA 01/2022
1	Nicotine FDA Link 08/2019
1	TicagrelorIBA 01/2019
1	Aprepitant (Emend)FDA Link 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 10/2018
1	tyrosine receptor (receptor, tyrosine)IBA 10/2018
1	ParaffinIBA 08/2018
1	copper-binding proteinIBA 01/2018
1	Ceruloplasmin (Ferroxidase)IBA 01/2018
1	Cyclophilin AIBA 11/2017
1	Immunoglobulins (Immunoglobulin)IBA 03/2017
1	MicroRNAs (MicroRNA)IBA 03/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	MethyltransferasesIBA 01/2016
1	moesinIBA 03/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2013
1	Complementary DNA (cDNA)IBA 11/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	Insulin-Like Growth Factor Binding Protein 1IBA 04/2011
1	Insulin-Like PeptidesIBA 04/2011

Therapy/Procedure

1	Therapeutics 01/2022
1	Oral Administration 01/2019